Auto-Injectors Market 2022: Driving Factors, Business Strategies and Market Size Forecast to 2027
Market Insights
Market
Research Future has revealed that the global autoinjectors market is expected
to witness exponential growth at a CAGR of over 25% during the forecast period
of 2018 to 2023. Autoinjectors are an advancement in healthcare which dispenses
a single dose of the given drug in an easy, and safe manner. Autoinjectors are
commonly known for their use in epinephrine pen which is used to offer
emergency care to patients suffering from anaphylactic shock.
Other
applications for autoinjectors in healthcare in addition to the above are
expected to spur growth for the global Auto-Injectors Market.
Increasing
prevalence of targeted therapies for the treatment of various conditions is
expected to increase market value. The growing diagnosis of diseases such as
diabetes and a general increase in anaphylaxis have increased the demand for
autoinjectors. Moreover, design development to increase efficiency and safety
with which medicine is delivered combined with technological advancements are
highly conducive to future opportunities for growth. However, stringent
government regulations for approval of medical products and the increasing
preference and demand for alternative drug delivery methods which are minimally
invasive are likely to hamper market growth to a certain extent. It should be noted
that the reimbursement scenario is favourable and the availability of generic
autoinjectors are expected to lead to a highly competitive market.
Key Players
Market
players profiled extensively in MRFR's report include Consort Medical, Owen
Mumford, Becton Dickinson and Company, Unilife Corporation, Eli Lily and
Company, Johnson & Johnson Services, Inc., AbbVie, Inc., Novartis
International AG, Antares Pharma, Bayer AG, Teva Pharmaceutical Industries
Ltd., Ypsomed, Amgen Inc., and SHL Group (Scandinavian Health Limited).
Market Segmentation
The
global Auto-Injectors
Market has been segmented based on therapy, type, distribution channel,
and region. by type, the market is divided between reusable autoinjectors and
disposable autoinjectors. By therapy, the autoinjector market is segmented into
diabetes, anaphylaxis, multiple sclerosis, rheumatoid arthritis, and others. By
distribution channel, the market includes hospital pharmacies, retail
pharmacies, and others.
The
regional segmentation of the global autoinjectors
market divides it into Europe, the Americas, the
Asia Pacific and the Middle East and Africa.
Regional Analysis
The
Americas make up the most significant share of the global market and is
followed closely by Europe which accounts for the second most significant
region. A high prevalence of auto-immune conditions such as widespread
allergies in these regions, combined with the availability of high-quality
health care, a high number of leading market players and availability of
research budgets act as crucial factors driving the growth of the autoinjectors
market.
Meanwhile,
the Asia Pacific is anticipated to grow at the highest CAGR during the forecast
period due to the presence of a massive patient population and consistently
growing economy. Emerging economies such as India are undergoing a
transformation in healthcare with increasing investments being made in
advancing the level of care offered in the region. A high diabetic population
also spurs the demand for autoinjectors in the region.
Latest Industry News
·
The FDA (Food & Drug Administration) has recently given
approval for the first generic version of the EpiPen auto-injector.
·
AstraZeneca has received approval for its new autoinjector pen
from the European Commission.
About US:
Market
Research Future (MRFR) enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99
Hudson Street,5Th Floor, New York,
New York
10013
Comments
Post a Comment